Primair lymfoedeem
1.
Bearda Bakker-Wensveen CAH, Van Duinen KF. Congenitale afwijkingen bij kinderen met lymfoedeem. Oedeminus. 2014
September: 3: 6-7.
2.
Buiting C, Njoo K. Richtlijn informatie uitwisseling tussen Huisarts en Specialist bij verwijzing (HASP). 2008. Nederlands
Huisartsen Genootschap.
3.
Connell FC, Gordon K, Brice G, Keeley V, Jeffrey S, Mortimer PS, et al. The classification and diagnostic algorithm for primary
lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013: 84: 303-314.
4.
Damstra RJ. Diagnostic and therapeutical aspects of lymphedema. Drachten; Stichting Lymfologie CentrumNederland; 2009.
5.
Damstra RJ, Mortimer PS. Diagnosis and therapy in children with lymphedema. Phlebology. 2008;23(6):276-86.
6.
Eijssens EC. Rapport ’Spierziekten als zeldzame ziekten in de huisartsenpraktijk’. 2006.
7.
Hendriks SA. Generieke zorgthema Huisartsgeneeskundige zorg. 2014.
www.zorgstandaarden.net/nl/wat-is-een-zeldzame- aandoening/generieke-zorgthemas.
8.
Gordon K, Spiden SL, Connell FC, Brice C, Cottrell S, Short J, et al. FLT4/VEGFR3 and Milroy disease; novel mutations a review of
published variants and database update. HumMutat. 2012. DOI: 10.1002/humu.22223.
9.
Joyce S, Gordon K, Brice C, Ostergaard P, Nagaraja R, Short J, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous
syndrome. Eur J HumGenet. 2015: 1-7.
10. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, WoollardWJ, et al. Mutations in GATA2 cause primary lymphedema
associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011. DOI: 10.1038/ng.923.
11. Ostergaard P, Simpson MA, Mendola A, Vasudevan P, Connell FC, Van Impel A, et al. Mutations in KIF11 Cause Autosomal-Dominant
Microcephaly Variably Associated with Congenital Lymphedema and Chorioretinopathy. Am J HumGenet (2012). DOI: 10.1016/j.
ajhg.2011.12.018.
12. Ozyurta A, Sevinc E, Baykan A, Arslan D, Argun M, Pamukcu O, et al. Variable clinical presentation in primary lymphoedema: report
of two cases. Clin Dysmorphol. 2014 (23): 83-87.
13. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics.
1985. 76 (2):206-18.
14. Van Balkom IDC, Alers M, Allason J, Bellini C, Frank U, De Jong G, et al. Lymphedema-Lymphangiectasia-Mental Retardation
(Hennekam) Syndrome: a review. Am J Med Genet. 2002. 112:412-421.
15. Van Steensel MAM, Damstra RJ, Heitink MV, Bladergroen RS, Veraart J, Steijlen PM, et al. Novel missense mutations in the FOXC2
gene alter transcriptional activity. HumMutat. 2009: 30: E1002-E1009.
16. Vinjé- Harrewijn A, Van Beek A, Haspels P. Omgaan met lymfoedeem. Bohn Stafleu& van Loghum; 2012.
17. Vreeburg M, Heitink MV, Damstra RJ, Moog U, Van Geel M, Van Steensel MAM. Lymphedema-distichiasis syndrome: a distinct type
of primary lymphedema caused by mutations in the FOXC2 gene. Int J Dermatol. 2008. 47(1):52-55.
18. Yu H, Littlewood T, Bennett M. Akt. isoforms in vascular disease, Vascul. Pharmacol. (2015),
http://dx.doi.org/10.1016/j.vph/2015.03.003.
19. Nederlandse Vereniging voor Dermatologie en Venereologie. Richtlijn Lymfoedeem. Utrecht: Nederlandse Vereniging voor
Dermatologie en Venereologie; 2014.
Literatuurlijst
14